$TAC

TAC Financials: Revenue Breakdown, Margins & Competitor Comparison

TransAlta Corp (TAC) generates most of its revenue from Gas, accounting for 53.0% of total sales, followed by Energy Transition and Hydro. The company displays a gross margin of 17.71%, with operating and net margins in negative territory, and a Return on Equity of -30.13%. TAC, with a market capitalization of $3.77B, competes with companies like TXNM and KEN, and its gross margin is significantly lower than TXNM's but comparable to KEN's.

Original reporting
Published Apr 1, 2026, 7:11 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 1, 2026, 7:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$TAC
Bearish
medium confidence
Mentioned
$TAC
alphai data visualization · based on Intellectia AI
Decision brief

The 30-second read

$TACBearishLow
01

Why it matters

The company's weak financials may lead to further stock decline, but sector-wide trends and potential strategic initiatives could influence future performance.

02

Market read

The news is relevant primarily to investors and traders focusing on the energy sector, especially those interested in gas and renewable energy companies.

03

What to watch

Regulatory changes, energy price fluctuations, and potential government support could alter the company's trajectory.

Timing: short-term to medium-term; financial results are recent and may influence near-term trading decisions.

Background

TAC's recent financial disclosures reveal operational challenges, with margins in negative territory and a negative ROE, raising concerns among investors.

Company-level read

Ticker impact

$TACBearishMedium confidence
Context

Primary focus of the news due to detailed financial analysis and market comparison.

Expected impact

Potential short-term decline due to weak financials and bearish sentiment, with a possible stabilization if operational improvements are announced.

Evidence & confidence

Financial metrics and market sentiment are clear indicators; however, external factors like energy prices and regulatory developments could influence outcomes.

Market effects

The energy sector, particularly gas and renewable energy segments, may experience volatility based on TAC's financial performance and strategic shifts.

Limited; TAC's operations are primarily regional, and its financial struggles are unlikely to significantly impact broader regional markets.

negligible; TAC's market cap and global influence are limited.

Counterpoint

Potential for turnaround if TAC can improve margins through cost reductions or strategic shifts, especially in renewable energy investments.

Key entities

  • TransAlta Corp

    A Canadian power generation and wholesale marketing company.

  • TXNM

    A competitor in the energy sector, with higher gross margins indicating better operational efficiency.

  • KEN

    Another competitor with similar gross margins, providing a benchmark for industry comparison.

Related articles

$TACMed

Across the Nutraverse: Probiotic foods in China, Akkermansia I.P., IM8’s $1bn financing deal

SAMR has drafted new China rules for probiotic health foods, open for consultation until Aug 24, 2026, including higher minimum CFU at shelf life and required strain details for traceability and quality. The Akkermansia Company received a new US patent covering marketing substantially purified Akkermansia for metabolic disorders, including live and pasteurized forms. IM8 secured $1bn growth financing from General Catalyst’s CVF to expand internationally.

$TACMed

The tab to keep a Northwest coal plant on standby keeps rising. Who will pay?

Utilities in the Pacific Northwest are contesting TransAlta’s request to recover costs for keeping its Centralia, Washington coal plant on standby under renewed Trump-era DOE emergency orders. TransAlta says its first April 30 invoice was nearly $20 million and estimates $23 million for repairs if standby extends into Q3–Q4 2026. FERC is reviewing opposition from utilities and grid operators.

$TACMedAI 8/10

TransAlta (NYSE:TAC) Stock Price Passes Above 200

TransAlta (NYSE:TAC) shares rose above their 200-day moving average on Monday, trading up to $13.82 and last at $13.5650. The 200-day average is $13.23. The article cites analyst actions including RBC and CIBC reiterating “outperform” and TD Securities “buy,” with MarketBeat showing a $21.33 consensus target. It also notes May 6 quarterly EPS of $0.04 vs $0.01 expected and a $0.07 quarterly dividend payable July 1.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.